We examined whether acceptability of nonabstinence treatment outcome goals varied as a function of a patient's severity of diagnosis (ICD-10 harmful use vs. dependence syndrome; World Health Organization, 1992), finality of outcome goal (intermediate vs. final), and type of substance (e.g., tobacco, alcohol, cannabis), among addiction treatment providers in Ukraine. We surveyed 44% of Ukrainian treatment providers (n ϭ 446/1023; M age ϭ 40.4, SD ϭ 8.6; Male ϭ 67%; M Years Of Experience ϭ 10.2, SD ϭ 7.2). For tobacco use, most respondents (78%-93%) rated nonabstinence as acceptable, regardless of diagnostic severity or finality of outcome goal (i.e., intermediate, final). Most respondents also rated nonabstinence as acceptable as an intermediate or final goal for patients with harmful use of alcohol (70% to 86%) or cannabis (71% to 93%); however, nonabstinence was less commonly indicated by respondents as an intermediate goal for patients with a dependence syndrome (alcohol ϭ 52%; cannabis ϭ 68%). Regarding other drug use, although most rated nonabstinence acceptable as an intermediate goal for patients with harmful use of opioids (68%) or sedatives (64%), fewer rated nonabstinence acceptable as a final goal (26% to 33%), particularly for patients with a dependence syndrome (10% to 27%). Very few providers (5% to 15%) rated nonabstinence acceptable for other substances. Patients in Ukraine who wish to moderate cannabis or tobacco use will find that their provider is typically accepting of this goal; however, providers are mixed regarding whether alcohol and opioid moderation is appropriate, particularly for those with dependence. Findings support education and research efforts to better understand how provider and patient alignment regarding goals impact patient outcomes following substance use treatment in Ukraine.
Global public health efforts to reduce substance use and related harms have focused on several approaches (MacCoun, 1998; Marlatt, Larimer, & Witkiewitz, 2012) , including demand reduction (e.g., abstinence-based education or psychotherapy), supply reduction (e.g., through drug interdiction efforts, control of prescription privileges, age limits for substance use/purchase), and harm reduction (e.g., needle exchange programs, medication-assisted treatment). One approach that serves as both demand and harm reduc-tion is helping patients diagnosed with a substance use disorder (SUD) to reduce or moderate/control their use of alcohol or drugs, either as an intermediate goal on the way toward abstinence or as a final goal. Definitions of moderate/controlled use-also referred to as nonabstinence-typically include two elements: a) a reduction in the quantity and/or frequency of use compared with one's current or problematic level of use, and b) a reduction in the number or severity of use-related problems (e.g., legal, medical, occupational, social, or familial problems; Rosenberg, 1993) .
Not only does this approach help reduce consumption and substance-related problems (Dunn & Strain, 2013) , it also supports a patient's autonomy and helps to build rapport/therapeutic alliance. These features are also consistent with a recovery-oriented systems of care model (Sheedy & Whitter, 2009; White, 2008) , which is focused on long-term healing, recognizes that there are many pathways into recovery, and has been suggested as a promising approach for treating those experiencing addiction and mental health problems in the United States (Moller & Fornili, 2016 ; Substance Abuse and Mental Health Services Administration & the Office of the Surgeon General, 2016). Supporting nonabstinence is also consistent with behavioral theories wherein people are more likely to achieve a goal when they have selected if for themselves compared with when a goal is prescribed for them (Bandura, 1986; Brehm & Brehm, 1985; Deci & Ryan, 1985) , which is reinforced by the notion that SUD interventions will be more effective if they match the substance use goal of the patient.
Although supporting nonabstinence has several therapeutic and public health advantages, there is limited evidence regarding the prevalence of successful moderation among patients with a SUD. The strongest evidence reveals that controlled drinking occurs frequently among patients with less severe alcohol use problems, and is infrequent-but about as common as complete abstinenceamong those with alcohol dependence (e.g., Maisto, Clifford, Stout, & Davis, 2007; Rosenberg, 1993; Saladin & Santa Ana, 2004; van Amsterdam & ven den Brink, 2013) . Additionally, compared with patients with a drinking goal of total abstinence, patients who pursue nonabstinence also experience reductions in alcohol use and related consequences and improvement in mental health following intervention (Dunn & Strain, 2013; Hasin et al., 2017; Witkiewitz, 2013) . Moreover, patients who reduce their drinking to nonrisky levels have similar outcomes as those who achieve abstinence in that both groups significantly improve in functioning compared with heavy drinkers . Although there are notably few studies from which to interpret the rates of successful moderation of illicit substances, similar to alcohol, moderation of cannabis use appears more common among those with less severe cannabis use problems (Stea, Yakovenko, & Hodgins, 2015) , and moderation of other illicit substances seems to be less prevalent than moderation of alcohol among patients with a SUD (Mertens, Kline-Simon, Delucchi, Moore, & Weisner, 2012) .
Despite the therapeutic, public health, and positive clinical outcomes associated with supporting reductions in substance use, accepting and encouraging patients who choose to pursue nonabstinence remains controversial, as evidenced by rates of acceptability among agency administrators and treatment providers in several countries. For example, research conducted in North America (Brochu, 1990; Davis & Rosenberg, 2013; Rosenberg & Davis, 1994 Rosenberg, Devine, & Rothrock, 1996; Rush & Ogborne, 1986) , Western Europe (Klingemann & Rosenberg, 2009; Robertson & Heather, 1982; Rosenberg & Melville, 2005; Rosenberg, Melville, Levell, & Hodge, 1992) , and Australia (Dawe & Richmond, 1997; Donovan & Heather, 1997) has found nonabstinence is more acceptable to agencies and providers in Western Europe, Canada, and Australia (e.g., 40% to 90% view these goals acceptable) compared with the United States (e.g., 9% to 44%). However, rates vary considerably depending on the type of substance a patient chooses to consume (alcohol vs. drugs), severity of their SUD (abuse vs. dependence), treatment setting (outpatient or residential), or finality of their outcome goal (initial/ intermediate or a final goal).
Although much is known about the acceptability of nonabstinence in predominately English-speaking countries, and a few non-English speaking countries in Western Europe, much less is known about the acceptability of such goals in Eastern Europe, where the World Health Organization (WHO) reports that substance use (especially alcohol use) and related problems are a major public health concern (WHO, 2014) . The only study that we could find assessing acceptability of nonabstinence in this region was conducted in Poland (Klingemann, 2016) . Findings revealed that 77% of alcohol treatment providers found nonabstinence acceptable for patients with alcohol abuse and 36% believed nonabstinence was acceptable for patients diagnosed with alcohol dependence, which is similar, albeit slightly less acceptable than it is in Western European countries and more acceptable than it is in the United States. Additionally, nonabstinence was more acceptable for Polish patients who selected this as an intermediate goal compared with a final goal, and younger professionals and women therapists were more in favor of nonabstinence compared with other providers (Klingemann, 2016) . Although this study increases understanding of the acceptability of nonabstinence in one country in Eastern Europe, prior studies found that acceptability varies by country, thus supporting the need to examine this question among providers in other Eastern European countries.
Therefore, we set out to examine the rates of acceptability of nonabstinence in the neighboring country of Ukraine. Highlighting the importance of this topic in this region, alcohol-attributable mortality risk is seven times higher in Eastern Europe than it is in other parts of Europe (WHO, 2016) . Specific to Ukraine, the prevalence of heavy episodic drinking (22.6%) and alcohol use disorder (4.9%), and the average amount of alcohol consumption per capita (13.9 L) are higher than most other European countries, and the risk to mortality and morbidity are also very substantial (WHO, 2014) . According to recent WHO data, Ukraine ranks sixth in the world in rate of alcohol consumption. Not surprisingly, rates of alcohol use are higher among Ukrainian males compared with females (WHO, 2014) . Moreover, over half of men and just over 10% of women in Ukraine are current, regular tobacco smokers, 47% to 62% of whom evidence dependence symptoms (Webb et al., 2007) , and approximately 76,000 Ukrainians were registered as drug users in 2014 (Bureau of International Narcotics & Law Enforcement Affairs, 2015) . Although over half a million Ukrainians are diagnosed with alcohol or drug dependence, only about one half were provided with treatment in 2016 (Ministry of Health, personal communication), underscoring the need for adequate access to addiction treatment. Because current monitoring and treatment practices are typically reserved for those with the most severe SUDs, efforts for early screening and brief or other outpatient This document is copyrighted by the American Psychological Association or one of its allied publishers.
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interventions for those in earlier stages of substance use problems are neglected, which limits the possibility of diverting a problematic substance use trajectory.
Current Study
Given the recent efforts from the WHO to reduce harms associated with alcohol use across this region (WHO, 2012) , and the importance of adopting early screening and brief interventions for Ukrainians with less severe substance use in order to prevent future problems, understanding the rates of acceptability of nonabstinence is an important step in identifying possible education and training needs for providers in this country, which could enhance the provision of early interventions in Ukraine. Therefore, the current study has two primary aims: (1) to examine the rates of acceptability of nonabstinent treatment outcome goals among addiction treatment providers in Ukraine, and (2) (Davis & Rosenberg, 2013; Klingemann, 2016; Rosenberg & Davis, 2014) , we hypothesized that acceptability of nonabstinence would be higher for those patients diagnosed with less severe substance use problems and for those who chose nonabstinence as an intermediate goal compared with those patients diagnosed with a dependence syndrome and who chose this as a final goal. On the basis of data showing that rates of acceptability vary depending on the specific type of substance one choses to consume (Rosenberg & Davis, 2014) , we also hypothesized that Ukrainian providers would find it more acceptable for a patient to pursue nonabstinence from alcohol or cannabis than for other substances (e.g., opioids, hallucinogens, methamphetamine, cocaine).
Because the primary reason that people receive addiction treatment in Ukraine is related to alcohol use, this study also has a secondary aim of evaluating whether acceptability of nonabstinence for alcohol use varies as a function of providers' geographic region, professional title, personal history of substance use problems, age, gender, or number of years working in the addiction treatment field. On the basis of findings from Klingemann (2016) , we hypothesized that younger professionals and women would be more accepting of nonabstinence compared with older, and male professionals.
Method Survey
The survey for this study was developed based on previously published questionnaires designed to assess the acceptability of nonabstinence goals by British and American administrators and counselors working in addiction treatment agencies (Davis & Rosenberg, 2013; Davis, Rosenberg, & Rosansky, 2017; Rosenberg & Davis, 2014; Rosenberg & Melville, 2005; Rosenberg & Phillips, 2003) . Each respondent was asked to rate how acceptable (completely acceptable ϭ ϩ2; somewhat acceptable ϭ ϩ1; somewhat unacceptable ϭ Ϫ1; completely unacceptable ϭ Ϫ2) it would be for a patient to pursue nonabstinence (defined as moderate or controlled use of a substance) as their intermediate or final outcome goal when they were diagnosed with one of 20 different types of substance use disorders: 10 types of substance-specific SUDs (alcohol, cannabis, opioids, sedatives, synthetic cathinones, methamphetamine, hallucinogens, tobacco, synthetic cannabis, cocaine) by two levels of diagnostic severity (ICD-10 harmful use, ICD-10 dependence syndrome; see column headings of Table 2 ). We also included questions evaluating respondents' demographic (e.g., age, gender, geographic region: Northern, Central, Western, Eastern, Southern) and educational/occupational characteristics (e.g., number of years providing services to patients with SUDs, education, field of training, types of patients treated). Respondents also answered questions about the client characteristics they considered when deciding whether nonabstinent treatment goals were acceptable, whether they considered the survey biased, and whether they had a personal history of substance use problems.
Survey Translation
Because prior surveys had been developed in English, the survey for this study was first created in English and then translated into Ukrainian. The translation process consisted of four steps: (1) a Ukrainian member of the study team translated the survey from English into Ukrainian; (2) the survey was translated back into English by a faculty member at a university in the United States who is fluent in both English and Ukrainian and licensed as a professional translator, but who was otherwise uninvolved with survey development; (3) this "back-translation" was compared with the original English version of the survey; and (4) discrepancies and any confusing phrases were retranslated by the study team to maximize clarity of expression/meaning. Both versions of the survey are available upon request from the corresponding author.
Recruitment and Procedure
The Ukrainian Ministry of Health maintains an electronic database of the identity and contact information for all addiction treatment providers in Ukraine. According to the Ministry of Health there are 1,023 registered addiction treatment providers across the country. Of these, 712 providers on this list have an e-mail address and 311 have a postal address as their primary method of contact. Ukrainian providers work in treatment facilities across all five major regions in Ukraine (Central, Northern, Eastern, Southern, and Western), and the facilities mostly comprise providers with one of four major professional roles: narcologist (i.e., a professional who is primarily responsible for managing substance detoxification and providing pharmacological treatment), psychologist (i.e., a professional who is primarily responsible for providing individual and group therapy), social worker (i.e., a professional who is primarily responsible for providing case management and social support in the community, and accessing occupational or financial resources), and peer support specialist (i.e., a paraprofessional with prior history of alcohol or drug problems who have achieved long-term abstinence and help with leading 12-step programs or religious activities). This document is copyrighted by the American Psychological Association or one of its allied publishers.
We developed a recruitment strategy to obtain a sample of approximately one half (i.e., 500/1023) of all Ukrainian providers, distributed across each geographical region, professional role, and notification method (e-mail or standard mail). Our primary recruitment method involved a representative from the Ukraine Ministry of Health sending an e-mail recruitment script several times per week for approximately five weeks (during May and June 2017) to the 712 addiction treatment providers with access to reliable e-mail. In this recruitment e-mail, potential respondents were informed about the purpose of the study, that it would take approximately 20 min to fill out the survey (see description to follow) and that their participation was voluntary and anonymous. As an incentive to participate, potential respondents were also notified that we would provide $US15 in compensation to each person who completed the electronic survey. We restricted the total possible sample size from e-mail recruitment method to 400 respondents in order to reserve 100 surveys (and incentives) for providers without reliable access to e-mail. After a potential respondent clicked the secure link to the screening website (hosted by Qualtrics.com) they were asked to report in which region they lived and their professional role. We used this information to determine if a potential respondent was eligible to participate based on two quotas that we electronically programmed into the survey software. Specifically, a provider was eligible if they were one of the first 80 providers from their region (in order to obtain a sample comprised of 20% of providers from each of five regions in Ukraine). Additionally, a potential respondent was eligible if they were one of the first 40 narcologists (50% of sample), 16 psychologists (20% of sample), 16 social workers (20% of sample), or eight peer support specialists (10% of sample) from their region (for a total of 80 participants from each of five regions in Ukraine). If a provider met these criteria, he or she was automatically sent to a second secure website (hosted by redcap.com) to provide informed consent and complete the full survey. After completing the study, each respondent was provided $US15 in compensation.
Our secondary recruitment method targeted rural providers who either did not have access to reliable e-mail or who provided only a postal address to the Ministry of Health. We obtained a list of 100 addresses for treatment providers (of the 311 on their list) to complete a paper version of the survey. Providers were randomly chosen based on region and professional title (20 providers from each of five regions; a total of 50 narcologists, 20 psychologists, 20 social workers, and 10 peer support specialists from across the country). We then sent by postal mail a paper copy of the recruitment script, informed consent document, survey, a paid return envelope and we provided them with the $US15 incentive as a way to encourage them to complete and return the materials. Surveys received by the study staff were then entered into the electronic survey software. The study was approved by the institutional review board at the first author's institution in the United States and at the second author's institution in Ukraine.
Data Analysis Plan
Primary aims. We conducted a series of frequency counts and descriptive analyses to summarize the demographic (e.g., age, gender) and occupational (e.g., years of professional experience, work environment, patient population served) characteristics of the sample. Next, we conducted four repeated-measures analyses of variance (ANOVAs) to examine whether mean ratings of acceptability of nonabstinence differed as a function of the type of substance a patient chose to moderate (i.e., alcohol, cannabis, opioids, sedatives, synthetic cathinones, hallucinogens, methamphetamine, tobacco, synthetic cannabis, cocaine), and level of SUD severity (ICD-10 harmful use vs. ICD-10 dependence syndrome), within both types of categories for the finality of the outcome goal (i.e., intermediate goal on the way toward abstinence or as a final goal). For each ANOVA we conducted follow-up post hoc tests of mean pairwise comparisons, and we used Bonferroni corrected alphas (␣ ϭ .05/40 ϭ .00125) to evaluate statistical significance of these post hoc tests. We then conducted frequency counts to summarize the ratings of importance for each of 19 client characteristics respondents considered when determining whether nonabstinence was acceptable.
Secondary aims. We conducted four repeated-measures ANOVAs to evaluate whether acceptability of nonabstinence for alcohol (harmful use/intermediate goal; harmful use/final goal; dependence syndrome/intermediate goal; dependence syndrome/final goal) differed as a function of geographical region of the respondent (Central, Northern, Eastern, Southern, Western). We then conducted 4 repeated-measures ANOVAs to evaluate whether acceptability of nonabstinence for alcohol (harmful use/intermediate goal; harmful use/final goal; dependence syndrome/intermediate goal; dependence syndrome/final goal) differed as a function of professional title of the respondent (narcologist, psychologist, social worker, peer support specialist). In each of these two sets of four ANOVAs we conducted follow-up post hoc tests of mean pairwise comparisons (Bonferroni corrected alphas .05/4 ϭ .0125). Next, we conducted 4 t tests to examine whether there were differences in mean ratings of acceptability of nonabstinence for alcohol (harmful use/intermediate goal; harmful use/final goal; dependence syndrome/intermediate goal; dependence syndrome/ final goal) as a function of whether a respondent endorsed a personal history of substance use problems (Bonferroni corrected alphas .05/4 ϭ .0125) or as a function of gender (Bonferroni corrected alphas .05/4 ϭ .0125). Last, we calculated Pearson product-moment correlation coefficients to determine whether there were any significant associations between respondents' age, number of years working in the addition treatment field and mean ratings of acceptability of nonabstinence (Bonferroni corrected alphas .05/6 ϭ .008). All analyses were conducted using SPSS Versions 22 and 24 (IBM Corp, 2013 .
Results
Following electronic mail recruitment, 576 people had clicked a secure link to our online survey and 427 (81%; 427/576) screened eligible and were presented with the informed consent document. Of these, 400 (69%; 400/427) consented to participate, completed the survey, and were provided with compensation. Following postal mail recruitment, 46 (46% of providers on the list; 46/100) had consented and returned the completed survey to the study site. Thus, the final sample was comprised of 446 respondents (44% of all registered providers in Ukraine; 446/1023). Total response rate was 55% (446/812). As Table 1 reveals, the majority of the sample reported they were male (67%), had a university degree (75%), and were middle-aged (M ϭ 40.4, SD ϭ 8.6), and had been in the This document is copyrighted by the American Psychological Association or one of its allied publishers.
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addiction treatment field for approximately 10 years (M ϭ 10.2, SD ϭ 7.2). A series of t tests and two-proportion z tests revealed that there were no significant differences in demographic (age, gender) or occupational (years of professional experience, populations served) characteristics as a function of whether a respondent completed an electronic or paper version of the survey (these data are not presented but are available upon request to the corresponding author).
Acceptability of Nonabstinence as an Intermediate Goal for ICD-10 Harmful Use by Type of Substance
The first analysis revealed that mean ratings of acceptability of nonabstinence as an intermediate outcome goal for clients diagnosed with harmful use (range Ϫ2 to 2) differed as a function of substance type among the 10 substances assessed, F(3.7, 1649.6 
(SD ϭ 1.0). Post hoc tests of mean pairwise comparisons revealed that nonabstinence from tobacco was significantly more acceptable than for any other substance. Additionally, there were no differences in the acceptability of nonabstinence for alcohol and cannabis relative to each other, but both were more acceptable than nonabstinence from both opioids and sedatives. Findings also revealed that there were no differences between ratings of acceptability of nonabstinence for the remaining five substances: synthetic cathinones, synthetic cannabis, hallucinogens, methamphetamine, and cocaine, and that nonabstinence was rated significantly more unacceptable for these five substances compared with all others. Moreover, as Table 2 (column 2) shows, a majority of respondents (between 64% and 93%) rated nonabstinence at least somewhat or completely acceptable for clients diagnosed with harmful use and who wanted to pursue nonabstinence from alcohol, cannabis, opioids, sedatives, or tobacco as an intermediate goal on the way toward complete abstinence.
Acceptability of Nonabstinence as a Final Goal for ICD-10 Harmful Use by Type of Substance
The second analysis revealed that mean ratings of acceptability of nonabstinence as a final outcome goal for clients diagnosed with Harmful Use (range Ϫ2 to 2) differed as a function of substance type, F(4.0, 1764.2) ϭ 780.7, p Ͻ .001, p 2 ϭ .64, M Tobacco ϭ 0.9 (1.0), M Alcohol ϭ 0.3 (1.2), M Cannabis ϭ 0.3 (1.1), M Opioids ϭ Ϫ0.5 (1.1), M Sedatives ϭ Ϫ0.7 (1.1), M SynthCannabis ϭ Ϫ1.7 (0.8), M SynthCathinones ϭ Ϫ1.8 (0.7), M Methamphetamine ϭ Ϫ1.8 (0.7), M Hallucinogens ϭ Ϫ1.8 (0.7), M Cocaine ϭ Ϫ1.8 (0.8). Post hoc tests of mean pairwise comparisons revealed that nonabstinence from tobacco was significantly more acceptable than for any other substance. Additionally, there were no differences in the acceptability of nonabstinence for alcohol and cannabis, which were both more acceptable than nonabstinence from opioids and sedatives. Further, acceptability of nonabstinence was significantly lower for opioids compared with sedatives. Findings also revealed that there were no differences between ratings of acceptability of acceptability of non-abstinence for the remaining five substances (synthetic cathinones, synthetic cannabis, hallucinogens, methamphetamine, and cocaine), and nonabstinence was rated the significantly more unacceptable for these five substances compared with all other substances. Moreover, as Table 2 (column 3) shows, a majority of respondents (between 70% and 90%) rated nonabstinence at least somewhat or completely acceptable for clients with harmful use and who wanted to pursue nonabstinence from alcohol, cannabis, or tobacco as a final goal.
Acceptability of Nonabstinence as an Intermediate Goal for ICD-10 Dependence Syndrome by Type of Substance
The third analysis revealed that mean ratings of acceptability of nonabstinence as an intermediate outcome goal for clients diagnosed with dependence syndrome (range Ϫ2 to 2) differed as a function of substance type, F(4.1, 1889.2) ϭ 683.3, p Ͻ .001, p 2 ϭ .61, M Tobacco ϭ 0.9 (0.9), M Cannabis ϭ 0.3 (1.2), M Alcohol ϭ Ϫ0.1 (1.2), M Opioids ϭ Ϫ0.6 (1.1), M Sedatives ϭ Ϫ0.8 (1.1), M SynthCannabis ϭ Ϫ1.6 (1.0), M Cocaine ϭ Ϫ1.6 (1.0), M SynthCathinones ϭ Ϫ1.7 (1.0), M Methamphetamine ϭ Ϫ1.7 (1.0), M Hallucinogens ϭ Ϫ1.7 (0.9). Post hoc tests of mean pairwise comparisons revealed that nonabstinence from tobacco was significantly more acceptable than for any other substance. Additionally, there were differences in the acceptability of nonabstinence for cannabis, alcohol, opioids, and sedatives (in descending order of acceptability), all four of which were significantly more acceptable that nonabstinence from any of the remaining substances. Findings also revealed that there were no differences between ratings of acceptability of nonabstinence for the remaining five substances (synthetic cathinones, synthetic cannabis, hallucinogens, methamphetamine, and cocaine). Moreover, as Table 2 (column 4) shows, a majority of respondents (between 52% and 91%) rated nonabstinence at least somewhat or completely acceptable for clients diagnosed with dependence syndrome and who wanted to pursue nonabstinence of alcohol, cannabis, or tobacco as an intermediate goal. This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Acceptability of Nonabstinence as a Final Goal for ICD-10 Dependence Syndrome by Type of Substance
The fourth analysis revealed that mean ratings of acceptability of nonabstinence as a final outcome goal for clients diagnosed with dependence syndrome (range Ϫ2 to 2) differed as a function of substance type, F(3.9, 1714.2 Post hoc tests of mean pairwise comparisons revealed that nonabstinence from tobacco was again significantly more acceptable than for any other substance. Additionally, there were no differences in the acceptability of acceptability of non-abstinence for alcohol, cannabis, opioids, and sedatives, all of which were more acceptable than nonabstinence from other substances. Findings also revealed that there were no differences between ratings of acceptability of nonabstinence for the remaining five substances (synthetic cathinones, synthetic cannabis, hallucinogens, methamphetamine, and cocaine). Moreover, as Table 2 (column 5) shows, tobacco was the only substance for which a majority of respondents (78%) rated nonabstinence at least somewhat or completely acceptable for clients diagnosed with dependence syndrome and who wanted to pursue nonabstinence as a final goal.
Client Characteristics and Acceptability of Nonabstinence
We assessed the importance of 19 listed patient characteristics that respondents might consider when deciding whether nonabstinence goals were acceptable. Examination of Table 3 reveals that over one half and sometimes over 90% of the sample reported that the patient's own choice of treatment goal, rapport/therapeutic alliance, motivation of the patient, social support network, emotional stability, co-occurring posttraumatic stress disorder/trauma, family support for controlled use, and comorbid psychiatric diagnoses were "very important" considerations when determining whether nonabstinence was acceptable. Most respondents rated all of the remaining characteristics (e.g., previous history of controlled use, homelessness) as "a little important", with the exception gender, which most rated as "not important" when determining whether nonabstinence was acceptable.
Differences in Acceptability for Pursuing Nonabstinence From Alcohol As a Function of Respondents' Characteristics
As a secondary aim, we examined whether there were differences in acceptability of nonabstinence as a function of respondents' geographic region, professional title, personal history of having substance use problems, age, gender, and number of years working with patients diagnosed with a SUD. First, we found that mean ratings of acceptability of nonabstinence from alcohol differed significantly as a function of geographic region within each variable pairing (e.g., harmful use/intermediate goal; dependence syndrome/final goal, etc.; see test results in Table 4 ). Overall, post hoc tests of mean pairwise comparisons revealed that there were relatively few differences in acceptability of nonabstinence for patients with a dependence syndrome and who chose to pursue controlled alcohol use as an intermediate or final outcome goal. However, mean ratings of acceptability of nonabstinence, for patients with harmful use of alcohol and who chose to pursue nonabstinence as an intermediate goal, were significantly lower in the Eastern region compared with the Central, Southern, and Western regions and there were no significant differences in acceptability across all other regions. Moreover, mean ratings of acceptability of nonabstinence, for patients with harmful use of alcohol and who chose to pursue nonabstinence as a final goal, were significantly lower in the Eastern and Southern regions compared with the Central region.
In the next analysis, we found that mean ratings of acceptability of nonabstinence differed significantly as a function of respondents' professional title (psychologist, narcologist, social worker, peer support specialist; see test results in Table 5 ). Overall, post hoc tests of mean pairwise comparisons revealed few differences in ratings of acceptability of nonabstinence for patients with harmful use or a dependence syndrome who pursue nonabstinence as an intermediate or final goal, but when they were significantly different it was typically peer support specialists and social workers that were the least accepting of these goals compared with psychologists and narcologists.
We also found significant differences between rates of acceptability as s function of whether providers did (n ϭ 50) or did not (n ϭ 348) report having a personal history of substance use problems. Specifically, we found significant difference in mean ratings of acceptability for patients diagnosed with harmful use of alcohol who pursue this as an intermediate goal (M SubstanceHistory ϭ Ϫ0.3, SD ϭ 1.3 vs. M SubstanceNoHistory ϭ 1.2, SD ϭ 1.0), t(396) ϭ 9.94, p Ͻ .001, or final goal (M SubstanceHistory ϭ Ϫ0.9, SD ϭ 1.2 vs. M SubstanceNoHistory ϭ 0.5, SD ϭ 1.1), t(396) ϭ 8.12, p Ͻ .001. Additionally, there This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
were differences in mean ratings of acceptability for patients diagnosed with a dependence syndrome who pursue this as an intermediate goal (M SubstanceHistory ϭ Ϫ0.9, SD ϭ 1.3 vs. M SubstanceNoHistory ϭ 0.1, SD ϭ 1.1), t(396) ϭ 5.67, p Ͻ .001, but not for those patients who pursue nonabstinence as a final goal (M SubstanceHistory ϭ Ϫ1.6, SD ϭ 1.0 vs. M SubstanceNoHistory ϭ Ϫ1.4, SD ϭ 1.0), t(396) ϭ 1.47, p ϭ .144. In each of these cases, it was those respondents with a history of substance use problems who rated nonabstinence goals as significantly less acceptable compared with those without a history of substance use problems. We found only one of four statistical tests were significant when examining differences in acceptability as a function of gender. Specifically, we found no differences (null findings not presented but available up request from the corresponding author) between those male (n ϭ 293) and female (n ϭ 143) providers in their mean ratings of acceptability of nonabstinence for patients diagnosed with harmful use of alcohol who pursue this as an intermediate or final goal. Additionally, there were no differences in their mean ratings of acceptability for patients diagnosed with a dependence syndrome who pursue this as an intermediate goal, but there was a significant provider gender difference in acceptability for patients who pursue nonabstinence as a final goal (M Female ϭ Ϫ1.2, SD ϭ 1.2 vs. M Male ϭ Ϫ1.5, SD ϭ 0.9), t(434) ϭ Ϫ3.10, p ϭ .002, indicating that women were slightly more accepting of nonabstinence compared with men. Taken together, there was very little variability in the rates of acceptability of nonabstinence as function of gender. Last, we found no significant and clinically meaningful (r Ͼ .30) associations between respondents' age or number of years working with patients diagnosed with SUDs, and mean ratings of acceptability of nonabstinence (data not presented by available upon request from the corresponding author).
Discussion
A nationwide sample of 446 addiction treatment providers in Ukraine completed a survey designed to assess whether acceptability of limited or moderate substance use (i.e., nonabstinence) varied as a function of a patient's substance-specific SUD (e.g., alcohol, cannabis, tobacco), level of SUD severity (ICD-10 harmful use vs. dependence syndrome), or the finality of their treatment outcome goal (intermediate vs. final) . With the exception of cannabis, most providers rated nonabstinence as somewhat or completely unacceptable for patients who choose to consume illicit substances (i.e., synthetic cathinones, synthetic cannabis, methamphetamine, cocaine, hallucinogens), regardless of SUD severity or finality of their outcome goal. Results also indicated that most respondents believed nonabstinence was acceptable for patients who use tobacco, regardless of SUD severity or finality of the outcome goal. Similarly, most respondents rated nonabstinence acceptable as an intermediate or final goal for patients with harmful use of alcohol or cannabis, or rated nonabstinence acceptable as an intermediate goal for patients with an alcohol or cannabis dependence; however, almost all providers rated nonabstinence unacceptable for patients diagnosed with cannabis dependence and alcohol dependence when pursued as a final goal. Although many providers rated nonabstinence acceptable as an intermediate goal for patients diagnosed with harmful use of opioids or sedatives, very few rated this as an acceptable final goal, or rated it acceptable for patients with a dependence syndrome.
With very few exceptions, these findings provide further evidence that agency administrators and addiction treatment providers across regions in both Eastern Europe (Klingemann, 2016) and Western Europe (Duckert, 1989; Klingemann & Rosenberg, 2009; Rosenberg & Melville, 2005; Rosenberg et al. 1992) believe that nonabstinence treatment outcome goals are generally acceptable, but more so for patients who are diagnosed with less severe Professional title
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disorders, which is consistent with the evidence supporting the efficacy of nonabstinence in reducing alcohol use and consequences (Dunn & Strain, 2013; Hasin et al., 2017; Witkiewitz, 2013; Witkiewitz et al., 2017) . Nevertheless, rates of acceptability differ slightly by country. For example, although the rates of acceptability of nonabstinence for patients with harmful use of alcohol in Ukraine were similar to those from a sample of alcohol treatment providers in Poland (Klingemann, 2016) , compared with Ukrainian providers, almost twice the proportion of Polish treatment providers believed that nonabstinence goals were acceptable for those patients with alcohol dependence who choose to pursue nonabstinence as a final goal. There are several possible explanations for this difference. For one, Poland has more indicators of social, economic and political stability compared with Ukraine (The Fund for Peace, 2017); it is thus possible that Polish providers, and the larger Polish treatment system have more access to financial and educational resources which influence the types of treatment approaches taught or offered. These economic advantages might also influence the amount of time that providers can spend working with a patient experiencing a severe alcohol use disorder and who decide to pursue nonabstinence, thereby making these goals more acceptable. A second explanation is that the level of alcohol abuse and dependence across the Ukrainian population is higher than it is in Poland (WHO, 2014), and therefore the danger of persons pursuing nonabstinence in Poland could be less threatening to providers because they have not so often seen substance use deteriorate into severe problems. Although our findings were largely consistent with studies conducted in Europe, they are to some degree inconsistent with studies conducted in North America (Davis & Rosenberg, 2013; Rosenberg & Davis, 2014) . For example, a recent study found that approximately 30% to 58% of providers in the United States rated nonabstinence acceptable for patients diagnosed with alcohol abuse (Davis & Rosenberg, 2013; Rosenberg & Davis, 2014) . Conversely, approximately twice the proportion of Ukrainian providers (70% to 86%) viewed these goals acceptable for patients with harmful alcohol use. These differences could be influenced by several factors, including the infrequency with which interventions are provided to those with less severe alcohol problems in Ukraine compared with the United States, and the strong history of abstinence-oriented treatment in the United States (Tracy, 2005) . Additionally, a larger proportion of Ukrainian providers rated nonabstinence acceptable as an intermediate goal for patients with severe alcohol use problems, but rates of acceptability of nonabstinence as a final goal are the same among providers in both countries (12%). Despite the evidence suggesting that reductions in alcohol consumption are associated with positive clinical outcomes, most providers in the United States and Ukraine report that reduction goals are unacceptable when alcohol use problems are severe, likely reflecting beliefs that the biomedical, psychological, and social risks of continued drinking outweigh any advantages of supporting reduced use. Conversely, it could simply be a lack of education and knowledge about the benefits of reduced drinking and lack of skills to support such goals, thus underscoring the need for continued education among treatment providers in both countries.
Because most studies examined the rates of acceptability of nonabstinence for patients diagnosed with an alcohol use disorder, there is very little data from which to compare our findings regarding the rates of acceptability of nonabstinence for patients with specific illicit drug use disorders. Nevertheless, a comparison of our data with data from a recent study in the United States (Rosenberg & Davis, 2014) , reveals striking similarities between providers in both countries. For example, rates of acceptability for cannabis use moderation were higher in the Ukraine when a patient was described as having less severe cannabis use problems, but rates in both countries declined as severity of cannabis use disorder increased and as the goal transitioned from intermediate to final. Additionally, when rates of acceptability differed between these two countries, it was typically providers in the United States that rated nonabstinence slightly more acceptable for patients with harmful use or dependence on synthetic cannabis, synthetic cathinone, methamphetamine, cocaine, or hallucinogens who pursue this as an intermediate goal (20% to 27%) compared with providers in Ukraine (8% to 15%). Conversely, Ukrainian providers rated nonabstinence more acceptable for patients with harmful use of opioids who pursue nonabstinence as an intermediate (64%) outcome goal compared with United States providers (25%). Moreover, 9% to 12% of United States providers rated nonabstinence acceptable as a final goal for patients diagnosed with amphetamine, heroin, cocaine, or ecstasy dependence, and 5% to 10% of providers in Ukraine rated nonabstinence acceptable as a final goal for patients diagnosed with an opioid, sedative, synthetic cannabis, synthetic cathinone, methamphetamine, cocaine, or hallucinogen dependence syndrome. Although conclusions from these studies can be influenced by recruitment methodology, representativeness of the samples, and other characteristics, taken together, these data suggest that there may be few differences in rates of acceptability of nonabstinence for patients who use illicit substances in the United States and Ukraine.
Several methodological limitations should be considered when evaluating the findings from the present study. For example, we recruited most respondents using an e-mail overture sent by the Ukrainian Ministry of Health, and some respondents may have been unwilling to participate or share their true beliefs due to fear of repercussions from the government. However, our attempts to guarantee anonymity of study data possibly attenuated this concern. Additionally, although we recruited approximately one half of all providers in Ukraine (stratified based on region and professional role in the addiction treatment system), there were no demographic data from which to compare our sample to the larger population of providers in order to determine representativeness. Similarly, we contacted a randomly chosen group of 100 rural providers who did not have reliable access to e-mail in order to recruit a hard-to-reach segment of the workforce, and we cannot rule out the possibility that views differ among providers we did not contact or who decided not to return a completed survey. However, that this study is the first comprehensive survey of addiction treatment providers in Ukraine, it thus provides a substantive foundation to inform future research. Furthermore, we did not ask respondents about the use of medication-assisted therapies (e.g., naltrexone, methadone, buprenorphine) that may be used for treatment of alcohol and opioid use disorders. We recommend that future research examine this question given that use of such therapies might influence providers' beliefs about the acceptability, or actual success, of nonabstinent outcome goals.
To the degree that our sample is representative of all addiction treatment providers in Ukraine, patients who wish to moderate their This document is copyrighted by the American Psychological Association or one of its allied publishers.
use of alcohol, cannabis, or tobacco, will typically find that their treatment provider is accepting of this goal, especially when this is a temporary goal on the way toward total abstinence in the future. However, most providers will find it unacceptable if the patient wants to continue using almost any of the illicit substances we listed on the questionnaires, regardless of the finality of the outcome goal or the severity of their SUD. Moreover, although there were several small, albeit statistically significant, differences in acceptability of nonabstinence as a function of geographical region, professional discipline, and gender, the acceptability of nonabstinence across providers in Ukraine is generally consistent and thus patients in these regions will likely face similar obstacles if they choose to pursue nonabstinence regardless of provider or geographical characteristics. Given the numerous challenges faced by those with severe SUDs, it is not surprising that large majorities of Ukrainian providers reported that nonabstinence goals were unacceptable. Although treatment providers may be thinking about the patient's health and well-being when they decline to support a patient who wishes to pursue nonabstinence, acceptance of nonabstinence respects the autonomy of the patient and could attract and engage in treatment those clients who might eventually be open to abstaining if they are unable to moderate successfully (Ambrogne, 2002) . Furthermore, accepting nonabstinence goals is consistent with a recovery-oriented systems of care model (Sheedy & Whitter, 2009) , with behavioral theory suggesting that patients will be more successful when they select their own goals (Bandura, 1986; Brehm & Brehm, 1985; Deci & Ryan, 1985) , and with clinical outcomes suggesting that patients who pursue reductions in substance use will also experience reductions in related consequences, and experience improvements in mental health functioning, following intervention (Dunn & Strain, 2013; Hasin et al., 2017; Witkiewitz et al., 2017) . Therefore, we recommend that education and research efforts are needed to better understand how provider and patient alignment regarding goals impacts patient outcomes following substance use treatment in Ukraine. These efforts may benefit from further dissemination of evidenced-based approaches that recognize the autonomy of the patient to choose which outcome goals are consistent with their values (e.g., motivational interviewing).
